🇺🇸 FDA
Patent

US 11166972

Compositions comprising nicotinamide riboside and a urolithin

granted A61KA61K2300/00A61K31/366

Quick answer

US patent 11166972 (Compositions comprising nicotinamide riboside and a urolithin) held by Amazentis SA expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Amazentis SA
Grant date
Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2300/00, A61K31/366, A61K31/706, A61K9/0053